Aclarion (ACON) Capital Expenditures (2024 - 2025)
Aclarion posted quarterly Capital Expenditures of $13726.0 for Q4 2025, up 168.35% year-on-year from $5115.0 in Q4 2024, and up 87.49% on a QoQ basis from $7321.0 in Q3 2025.
Aclarion (ACON) has 2 years of Capital Expenditures data on file, last reported at $13726.0 in Q4 2025.
- For the quarter ending Q4 2025, Capital Expenditures rose 168.35% year-over-year to $13726.0; the trailing twelve-month figure through Dec 2025 stood at $26162.0 (changed N/A YoY), and the FY2025 full-year result was $21528.0, up 320.88% from the prior year.
- Capital Expenditures for Q4 2025 stood at $13726.0, up from $7321.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $13726.0 in Q4 2025 and bottomed at $5115.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 7.03 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 3.67 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 15.93 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 28,000.00 |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 2.25 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 15.33 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 118,000.00 |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 12.44 Mn |
| 10 | Aclarion | 7.18 Mn | -11.57 Mn | 3,750.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13,726.00 |
| Dec 31, 2025 | 13,726.00 |
| Sep 30, 2025 | 7,321.00 |
| Sep 30, 2025 | 7,321.00 |
| Dec 31, 2024 | 5,115.00 |
| Dec 31, 2024 | 5,115.00 |